Is treatment-resistant depression a useful concept?

Evidence-Based Mental Health

Volumn 19, Issue 1, 2016, Pages 1-3

  Malhi, Gin S ^a,b,c   Byrow, Yulisha ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMAN;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS;

EID: 84955262240     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/eb-2015-102299     Document Type: Article

References (20)

1. Caddy C, Amit BH, McCloud TL, et al. Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev2015; 9: CD011612.
2. Lavretsky H, Reinlieb M, St Cyr N, et al. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry2015; 172: 561-9.
3. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder. J Clin Psychiatry2014; 75: 1394-401.
4. Dougherty DD, Rezai AR, Carpenter LL, et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry2015; 78: 240-8.
5. Kayser S, Bewernick BH, Matusch A, et al. Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychol Med2015; 45: 1073-92.
6. Fostick L, Silberman A, Beckman M, et al. The economic impact of depression: resistance or severity? Eur Neuropsychopharmacol2010; 20: 671-5.
7. Ivanova JI, Birnbaum HG, Kidolezi Y, et al. Direct and indirect costs of employees with treatment-resistant and non-treatment resistant major depressive disorder. Curr Med Res Opinion2010; 26: 2475-84.
8. Fekadu A, Wooderson SC, Markopoulo K, et al. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord2009; 116: 4-11.
9. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53: 649-59.
10. RushAJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacol 2006; 31: 1841-53.
11. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust New Zeal J Psychiatry2015; 49: 1087-206.
12. Murray G. You say you want a revolution: recovery, biomedicine and muddling through. Aust New Zeal J Psychiatry2015; 49: 1085-6.
13. Nierenberg A, Husain M, Trivedi M, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med2010; 40: 41-50.
14. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry1997; 58: 23-9.
15. Souery D, Amsterdam J, de Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharm 1999; 9: 83-91.
16. Oquendo MA, Baca-Garcia E, Kartachov A, et al. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry2003; 64: 825-33.
17. Fekadu A, Wooderson S, Donaldson C, et al. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry 2009; 70: 177-84.
18. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D Project results: a comprehensive review offindings. Curr Psychiatry Rep2007; 9: 449-59.
19. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry2006; 163: 1905.
20. Harmer CJ, Goodwin GM, Cowen PJ. Why do antidperssants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 2009; 195: 102-8.